Elucid launches PlaqueIQ image analysis software for carotid arteries

Elucid has announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque morphology in the carotid arteries. According to the company, as the “first and only” computed tomography (CT)-based plaque analysis software indicated for the…
New project will develop nanoparticles with imaging and medicine-delivery capabilities to better treat PAD

A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD), the university announced in a press release. Kytai Nguyen, a UTA bioengineering…
Georgia Tech researchers develop wireless implantable vascular monitoring system
Researcher Woon-Hong Yeo and his collaborators at the Georgia Institute of Technology (Atlanta, USA) are trying to improve the odds for vascular patients with development of an implantable soft electronic monitoring system. Their new device, according to a Georgia Tech…
Depression linked to more prevalent subclinical atherosclerosis in women with HIV

Women living with HIV who reported a high burden of psychosocial risk factors like symptoms of depression, stress and post-traumatic stress disorder (PTSD) were more likely to have prevalent subclinical atherosclerosis compared with those indicating a low burden, a study…
SVS reports on vascular surgeon concerns over pandemic health impacts

Vascular surgeons from across the country are reporting health impacts on some patients—particularly elderly ones—in quarantine, the Society for Vascular Surgery (SVS) reports. The SVS queried vascular surgeons regarding their concerns for patients’ health during the pandemic and shared its…
Combining aspirin with rivaroxaban reduces risk equally in presence or absence of diabetes

In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients with and without diabetes, a prespecified analysis of the COMPASS trial has shown. It also noted…
VRIC agenda taking shape, poster sessions to return

The biology of vascular disease—including molecular mechanisms and the immune system—will take center stage on May 4 in Chicago at the 2020 Vascular Research Initiatives Conference (VRIC) meeting of the Society for Vascular Surgery (SVS). The conference, VRIC Chicago 2020:…

